The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bio Simulation-Global Market Insights and Sales Trends 2025
Synopsis
Biosimulation is computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology.
The global Bio Simulation market size is expected to reach US$ 2926.1 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Bio Simulation in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Other End Users,, are propelling Bio Simulation market. Software, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bio Simulation market, driven by demand from China, the second largest economy with some signs of stabilising, the Bio Simulation market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bio Simulation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bio Simulation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bio Simulation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bio Simulation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bio Simulation covered in this report include Altair Engineering Inc., ANSYS Inc., Certara LP, Dassault Systemes SE, Genedata AG, Intelligen Inc., Physiomics Plc, PPD Inc. and Schrodinger Inc., etc.
The global Bio Simulation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Altair Engineering Inc.
ANSYS Inc.
Certara LP
Dassault Systemes SE
Genedata AG
Intelligen Inc.
Physiomics Plc
PPD Inc.
Schrodinger Inc.
Simulations Plus Inc.
Rhenovia Pharma
Medtronic
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation
Global Bio Simulation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bio Simulation market, Segment by Type:
Software
Services
Global Bio Simulation market, by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bio Simulation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Biosimulation is computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology.
The global Bio Simulation market size is expected to reach US$ 2926.1 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Bio Simulation in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Other End Users,, are propelling Bio Simulation market. Software, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bio Simulation market, driven by demand from China, the second largest economy with some signs of stabilising, the Bio Simulation market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bio Simulation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bio Simulation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bio Simulation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bio Simulation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bio Simulation covered in this report include Altair Engineering Inc., ANSYS Inc., Certara LP, Dassault Systemes SE, Genedata AG, Intelligen Inc., Physiomics Plc, PPD Inc. and Schrodinger Inc., etc.
The global Bio Simulation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Altair Engineering Inc.
ANSYS Inc.
Certara LP
Dassault Systemes SE
Genedata AG
Intelligen Inc.
Physiomics Plc
PPD Inc.
Schrodinger Inc.
Simulations Plus Inc.
Rhenovia Pharma
Medtronic
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation
Global Bio Simulation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bio Simulation market, Segment by Type:
Software
Services
Global Bio Simulation market, by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bio Simulation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bio Simulation
1.1 Bio Simulation Market Overview
1.1.1 Bio Simulation Product Scope
1.1.2 Bio Simulation Market Status and Outlook
1.2 Global Bio Simulation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bio Simulation Market Size by Region (2018-2029)
1.4 Global Bio Simulation Historic Market Size by Region (2018-2023)
1.5 Global Bio Simulation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bio Simulation Market Size (2018-2029)
1.6.1 North America Bio Simulation Market Size (2018-2029)
1.6.2 Europe Bio Simulation Market Size (2018-2029)
1.6.3 Asia-Pacific Bio Simulation Market Size (2018-2029)
1.6.4 Latin America Bio Simulation Market Size (2018-2029)
1.6.5 Middle East & Africa Bio Simulation Market Size (2018-2029)
2 Bio Simulation Market by Type
2.1 Introduction
2.1.1 Software
2.1.2 Services
2.2 Global Bio Simulation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bio Simulation Historic Market Size by Type (2018-2023)
2.2.2 Global Bio Simulation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bio Simulation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bio Simulation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bio Simulation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bio Simulation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bio Simulation Revenue Breakdown by Type (2018-2029)
3 Bio Simulation Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biotechnology Companies
3.1.2 Contract Research Organizations
3.1.3 Other End Users
3.2 Global Bio Simulation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bio Simulation Historic Market Size by Application (2018-2023)
3.2.2 Global Bio Simulation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bio Simulation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bio Simulation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bio Simulation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bio Simulation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bio Simulation Revenue Breakdown by Application (2018-2029)
4 Bio Simulation Competition Analysis by Players
4.1 Global Bio Simulation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio Simulation as of 2022)
4.3 Date of Key Players Enter into Bio Simulation Market
4.4 Global Top Players Bio Simulation Headquarters and Area Served
4.5 Key Players Bio Simulation Product Solution and Service
4.6 Competitive Status
4.6.1 Bio Simulation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Altair Engineering Inc.
5.1.1 Altair Engineering Inc. Profile
5.1.2 Altair Engineering Inc. Main Business
5.1.3 Altair Engineering Inc. Bio Simulation Products, Services and Solutions
5.1.4 Altair Engineering Inc. Bio Simulation Revenue (US$ Million) & (2018-2023)
5.1.5 Altair Engineering Inc. Recent Developments
5.2 ANSYS Inc.
5.2.1 ANSYS Inc. Profile
5.2.2 ANSYS Inc. Main Business
5.2.3 ANSYS Inc. Bio Simulation Products, Services and Solutions
5.2.4 ANSYS Inc. Bio Simulation Revenue (US$ Million) & (2018-2023)
5.2.5 ANSYS Inc. Recent Developments
5.3 Certara LP
5.3.1 Certara LP Profile
5.3.2 Certara LP Main Business
5.3.3 Certara LP Bio Simulation Products, Services and Solutions
5.3.4 Certara LP Bio Simulation Revenue (US$ Million) & (2018-2023)
5.3.5 Dassault Systemes SE Recent Developments
5.4 Dassault Systemes SE
5.4.1 Dassault Systemes SE Profile
5.4.2 Dassault Systemes SE Main Business
5.4.3 Dassault Systemes SE Bio Simulation Products, Services and Solutions
5.4.4 Dassault Systemes SE Bio Simulation Revenue (US$ Million) & (2018-2023)
5.4.5 Dassault Systemes SE Recent Developments
5.5 Genedata AG
5.5.1 Genedata AG Profile
5.5.2 Genedata AG Main Business
5.5.3 Genedata AG Bio Simulation Products, Services and Solutions
5.5.4 Genedata AG Bio Simulation Revenue (US$ Million) & (2018-2023)
5.5.5 Genedata AG Recent Developments
5.6 Intelligen Inc.
5.6.1 Intelligen Inc. Profile
5.6.2 Intelligen Inc. Main Business
5.6.3 Intelligen Inc. Bio Simulation Products, Services and Solutions
5.6.4 Intelligen Inc. Bio Simulation Revenue (US$ Million) & (2018-2023)
5.6.5 Intelligen Inc. Recent Developments
5.7 Physiomics Plc
5.7.1 Physiomics Plc Profile
5.7.2 Physiomics Plc Main Business
5.7.3 Physiomics Plc Bio Simulation Products, Services and Solutions
5.7.4 Physiomics Plc Bio Simulation Revenue (US$ Million) & (2018-2023)
5.7.5 Physiomics Plc Recent Developments
5.8 PPD Inc.
5.8.1 PPD Inc. Profile
5.8.2 PPD Inc. Main Business
5.8.3 PPD Inc. Bio Simulation Products, Services and Solutions
5.8.4 PPD Inc. Bio Simulation Revenue (US$ Million) & (2018-2023)
5.8.5 PPD Inc. Recent Developments
5.9 Schrodinger Inc.
5.9.1 Schrodinger Inc. Profile
5.9.2 Schrodinger Inc. Main Business
5.9.3 Schrodinger Inc. Bio Simulation Products, Services and Solutions
5.9.4 Schrodinger Inc. Bio Simulation Revenue (US$ Million) & (2018-2023)
5.9.5 Schrodinger Inc. Recent Developments
5.10 Simulations Plus Inc.
5.10.1 Simulations Plus Inc. Profile
5.10.2 Simulations Plus Inc. Main Business
5.10.3 Simulations Plus Inc. Bio Simulation Products, Services and Solutions
5.10.4 Simulations Plus Inc. Bio Simulation Revenue (US$ Million) & (2018-2023)
5.10.5 Simulations Plus Inc. Recent Developments
5.11 Rhenovia Pharma
5.11.1 Rhenovia Pharma Profile
5.11.2 Rhenovia Pharma Main Business
5.11.3 Rhenovia Pharma Bio Simulation Products, Services and Solutions
5.11.4 Rhenovia Pharma Bio Simulation Revenue (US$ Million) & (2018-2023)
5.11.5 Rhenovia Pharma Recent Developments
5.12 Medtronic
5.12.1 Medtronic Profile
5.12.2 Medtronic Main Business
5.12.3 Medtronic Bio Simulation Products, Services and Solutions
5.12.4 Medtronic Bio Simulation Revenue (US$ Million) & (2018-2023)
5.12.5 Medtronic Recent Developments
5.13 Advanced Chemistry Development
5.13.1 Advanced Chemistry Development Profile
5.13.2 Advanced Chemistry Development Main Business
5.13.3 Advanced Chemistry Development Bio Simulation Products, Services and Solutions
5.13.4 Advanced Chemistry Development Bio Simulation Revenue (US$ Million) & (2018-2023)
5.13.5 Advanced Chemistry Development Recent Developments
5.14 Chemical Computing Group
5.14.1 Chemical Computing Group Profile
5.14.2 Chemical Computing Group Main Business
5.14.3 Chemical Computing Group Bio Simulation Products, Services and Solutions
5.14.4 Chemical Computing Group Bio Simulation Revenue (US$ Million) & (2018-2023)
5.14.5 Chemical Computing Group Recent Developments
5.15 Entelos Holding Corporation
5.15.1 Entelos Holding Corporation Profile
5.15.2 Entelos Holding Corporation Main Business
5.15.3 Entelos Holding Corporation Bio Simulation Products, Services and Solutions
5.15.4 Entelos Holding Corporation Bio Simulation Revenue (US$ Million) & (2018-2023)
5.15.5 Entelos Holding Corporation Recent Developments
6 North America
6.1 North America Bio Simulation Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bio Simulation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bio Simulation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bio Simulation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bio Simulation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bio Simulation Market Dynamics
11.1 Bio Simulation Industry Trends
11.2 Bio Simulation Market Drivers
11.3 Bio Simulation Market Challenges
11.4 Bio Simulation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
